SILVERARC CAPITAL MANAGEMENT, LLC - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
SILVERARC CAPITAL MANAGEMENT, LLC ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$159,101
+23.3%
961,338
+1822.7%
0.05%
-30.0%
Q1 2021$129,00050,0000.07%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 5,628,585$5,853,7285.06%
Aquilo Capital Management, LLC 4,552,876$4,734,9911.78%
BVF INC/IL 5,080,320$5,283,5330.22%
Soleus Capital Management, L.P. 1,000,000$1,040,0000.15%
Cutter & CO Brokerage, Inc. 378,479$393,6180.13%
PLATINUM INVESTMENT MANAGEMENT LTD 1,220,798$1,269,6300.05%
GSA CAPITAL PARTNERS LLP 365,047$3800.05%
Annandale Capital, LLC 67,000$700.02%
WEALTH EFFECTS LLC 21,700$22,5680.01%
Sigma Planning Corp 343,934$357,6910.01%
View complete list of PIERIS PHARMACEUTICALS INC shareholders